CFDE Data Portal | Search C3P1

	Label	Description
	C3P1 associations Collection (Entity type)	Associations for C3P1_associations
	C3P1 associations.tsv File (Entity type)	A file from IDG as part of the Harmonizome project
	C3P1 Gene (Entity type)	ENSG00000291164 - complement 3 precursor pseudogene
	GSE216043 cisplatin 11 v 1 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE179235 MEK NRAS inhibition 0 v 6 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE173116 GSE173118 ML-7 8 v 0 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE179235 MEK NRAS inhibition 4 v 6 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE158632 quinoline HT-29 Caco-2 3 v 4 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE139540 menadione 4 v 1 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE111247 temozolomide LN-308 14 v 5 human up Gene Set (Entity type)	A Gene Set from LINCS

C3P1 associations

Associations for C3P1_associations

C3P1 associations.tsv

A file from IDG as part of the Harmonizome project

C3P1

ENSG00000291164 - complement 3 precursor pseudogene

GSE216043 cisplatin 11 v 1 human dn

A Gene Set from LINCS

GSE179235 MEK NRAS inhibition 0 v 6 human up

A Gene Set from LINCS

GSE173116 GSE173118 ML-7 8 v 0 human dn

A Gene Set from LINCS

GSE179235 MEK NRAS inhibition 4 v 6 human up

A Gene Set from LINCS

GSE158632 quinoline HT-29 Caco-2 3 v 4 human dn

A Gene Set from LINCS

GSE139540 menadione 4 v 1 human up

A Gene Set from LINCS

GSE111247 temozolomide LN-308 14 v 5 human up

A Gene Set from LINCS

DISPLAY PER PAGE

@CFDE Workbench 2026

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2026

This repository is under review for potential modification in compliance with Administration directives.